Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data
- PMID: 25022435
- DOI: 10.1016/S1473-3099(14)70780-7
Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data
Erratum in
-
Corrections.Lancet Infect Dis. 2017 Sep;17(9):897. doi: 10.1016/S1473-3099(17)30241-4. Epub 2017 May 3. Lancet Infect Dis. 2017. PMID: 28478936 No abstract available.
Abstract
Background: Antibiotic drug consumption is a major driver of antibiotic resistance. Variations in antibiotic resistance across countries are attributable, in part, to different volumes and patterns for antibiotic consumption. We aimed to assess variations in consumption to assist monitoring of the rise of resistance and development of rational-use policies and to provide a baseline for future assessment.
Methods: With use of sales data for retail and hospital pharmacies from the IMS Health MIDAS database, we reviewed trends for consumption of standard units of antibiotics between 2000 and 2010 for 71 countries. We used compound annual growth rates to assess temporal differences in consumption for each country and Fourier series and regression methods to assess seasonal differences in consumption in 63 of the countries.
Findings: Between 2000 and 2010, consumption of antibiotic drugs increased by 36% (from 54 083 964 813 standard units to 73 620 748 816 standard units). Brazil, Russia, India, China, and South Africa accounted for 76% of this increase. In most countries, antibiotic consumption varied significantly with season. There was increased consumption of carbapenems (45%) and polymixins (13%), two last-resort classes of antibiotic drugs.
Interpretation: The rise of antibiotic consumption and the increase in use of last-resort antibiotic drugs raises serious concerns for public health. Appropriate use of antibiotics in developing countries should be encouraged. However, to prevent a striking rise in resistance in low-income and middle-income countries with large populations and to preserve antibiotic efficacy worldwide, programmes that promote rational use through coordinated efforts by the international community should be a priority.
Funding: US Department of Homeland Security, Bill & Melinda Gates Foundation, US National Institutes of Health, Princeton Grand Challenges Program.
Copyright © 2014 Elsevier Ltd. All rights reserved.
Comment in
-
Let the games begin: the race to optimise antibiotic use.Lancet Infect Dis. 2014 Aug;14(8):667-668. doi: 10.1016/S1473-3099(14)70809-6. Epub 2014 Jul 9. Lancet Infect Dis. 2014. PMID: 25022437 No abstract available.
-
Overconsumption of antibiotics.Lancet Infect Dis. 2015 Apr;15(4):377-8. doi: 10.1016/S1473-3099(15)70083-6. Lancet Infect Dis. 2015. PMID: 25809891 No abstract available.
-
Overconsumption of antibiotics.Lancet Infect Dis. 2015 Apr;15(4):377. doi: 10.1016/S1473-3099(15)70081-2. Lancet Infect Dis. 2015. PMID: 25809892 No abstract available.
-
Correction to global antibiotic consumption data.Lancet Infect Dis. 2017 May;17(5):476-477. doi: 10.1016/S1473-3099(17)30187-1. Lancet Infect Dis. 2017. PMID: 28447946 No abstract available.
Similar articles
-
Assessment of WHO antibiotic consumption and access targets in 76 countries, 2000-15: an analysis of pharmaceutical sales data.Lancet Infect Dis. 2021 Jan;21(1):107-115. doi: 10.1016/S1473-3099(20)30332-7. Epub 2020 Jul 24. Lancet Infect Dis. 2021. PMID: 32717205
-
Consumption of oral antibiotic formulations for young children according to the WHO Access, Watch, Reserve (AWaRe) antibiotic groups: an analysis of sales data from 70 middle-income and high-income countries.Lancet Infect Dis. 2019 Jan;19(1):67-75. doi: 10.1016/S1473-3099(18)30547-4. Epub 2018 Dec 3. Lancet Infect Dis. 2019. PMID: 30522834
-
Community level antibiotic utilization in India and its comparison vis-à-vis European countries: Evidence from pharmaceutical sales data.PLoS One. 2018 Oct 17;13(10):e0204805. doi: 10.1371/journal.pone.0204805. eCollection 2018. PLoS One. 2018. PMID: 30332450 Free PMC article.
-
Analysing policy interventions to prohibit over-the-counter antibiotic sales in four Latin American countries.Trop Med Int Health. 2013 Jun;18(6):665-73. doi: 10.1111/tmi.12096. Epub 2013 Mar 29. Trop Med Int Health. 2013. PMID: 23551290 Review.
-
Measuring antibiotic consumption in low-income countries: a systematic review and integrative approach.Int J Antimicrob Agents. 2016 Jul;48(1):27-32. doi: 10.1016/j.ijantimicag.2016.04.024. Epub 2016 May 26. Int J Antimicrob Agents. 2016. PMID: 27318624 Review.
Cited by
-
Antimicrobial Resistance in the Food Chain: Trends, Mechanisms, Pathways, and Possible Regulation Strategies.Foods. 2022 Sep 22;11(19):2966. doi: 10.3390/foods11192966. Foods. 2022. PMID: 36230040 Free PMC article. Review.
-
Local Epidemiology of Nosocomial Staphylococcus aureus Infection in a Nigerian University Teaching Hospital.Antibiotics (Basel). 2022 Oct 7;11(10):1372. doi: 10.3390/antibiotics11101372. Antibiotics (Basel). 2022. PMID: 36290030 Free PMC article.
-
Surveillance of antimicrobial utilization in Africa: a systematic review and meta-analysis of prescription rates, indications, and quality of use from point prevalence surveys.Antimicrob Resist Infect Control. 2024 Sep 11;13(1):101. doi: 10.1186/s13756-024-01462-w. Antimicrob Resist Infect Control. 2024. PMID: 39256804 Free PMC article.
-
Metabolomic Response of Thalassiosira weissflogii to Erythromycin Stress: Detoxification Systems, Steroidal Metabolites, and Energy Metabolism.Plants (Basel). 2024 Jan 25;13(3):354. doi: 10.3390/plants13030354. Plants (Basel). 2024. PMID: 38337887 Free PMC article.
-
The impact of sanction and healthcare system reform on the healthcare performance and pharmaceutical market in Iran; 2001-2016.J Pharm Policy Pract. 2020 Aug 27;13:50. doi: 10.1186/s40545-020-00245-z. eCollection 2020. J Pharm Policy Pract. 2020. PMID: 32864145 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical